CURRENT MEDICINAL CHEMISTRY RESEARCH - THOMSON REUTERS INTEGRITY
ESSENTIAL DATABASE TO EMPOWER YOU DRUG DISCOVERY AND DEVELOPMENT
Populated, refined, and supported by PhD scientists the Thomson Reuters Integrity database combines biology, chemistry and pharmacology information to deliver the latest insights into drug discovery and development.
Please complete the form for more information on Integrity and to get a free demo or trial.
From a chemist's perspective with Integrity you can:
- Search based on mechanism of action, structure, or drug name
- Understand the drug-target landscape
- Create structure-activity relationship tables
- Link to experimental data and all references
- View the latest structures, scaffolds and synthetic routes emerging from conferences, literature and patents
- Access "Disease Briefing" reviews on the current status and future trends in drug therapy for specific diseases
"I always use Integrity first in my search for information," says Nick Ray, Director of Chemistry. "It would be very difficult to find rapidly the answers to the questions we ask without it. I wouldn't have any confidence pulling that information through other sources."
GET FOCUSED INFORMATION FAST BY SEARCHING INTEGRITY'S:
- 330,000+ compounds with demonstrated biological activity
- 150,000+ patent families
- 900,000+ measured experimental pharmacology values
- 21,000+ synthesis schemes for drugs currently on the market or in development worldwide
- 93,000+ intermediates
RESEARCH IN ACTION:
- Case Study: Argenta drug discovery made easier with Integrity
- Case Study: Disease Detectives
- Case Study: The Problem With Cancer